About me
Dr. Inglis has over 25+ years of experience in clinical research, spanning all phases of research, specializing in clinical operations. While at Mallinckrodt Pharmaceuticals, she led the initiative to define the Risk Based Quality Management approach within Clinical Development. In addition to her current role at GSK where she is accountable for the operational delivery of assigned vaccine assets, she is also the Program Lead for the Risk Based Quality Management Approach for Clinical Studies initiative.
